CCE News Alert Coca-Cola Enterprises (CCE) 43.17 12/12/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Coca-Cola Enterprises (CCE) 43.17 $CCE

SmarTrend Watching for Potential Pullback in Shares of Coca-Cola Enterprises After 1.23% Gain
Comtex SmarTrend(R) - Thu Dec 11, 4:07PM CST
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $43.53 to a high of $44.62. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $44.18 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CCE: 43.17 (-1.11)

Look for Shares of Coca-Cola Enterprises to Potentially Pullback after Yesterday's 1.23% Rise
Comtex SmarTrend(R) - Thu Dec 11, 4:07PM CST
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $43.53 to a high of $44.62. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $44.18 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CCE: 43.17 (-1.11)

Third Quarter Earnings Season in Review: Sector Winners and Losers, the Misleading “Record” Beat Rate, and the Outlook for Q4
ESTMZ - Wed Dec 03, 11:31AM CST
On Monday, the third quarter earnings season will officially close out, with H&R Block as the final S&P 500 company to report. The season is ending with impressive earnings growth of 11.7%, paired with revenue growth of 4.8%, proving that...
KSS: 57.27 (+0.37), AMZN: 307.32 (-0.04), BIIB: 344.49 (+2.16), GE: 24.89 (-0.52), NKE: 96.17 (-0.76), BBY: 36.85 (+0.22), XOM: 86.60 (-2.60), KORS: 76.97 (+0.27), CCE: 43.17 (-1.11), PVH: 127.03 (+1.47), URBN: 32.06 (-0.23), NFLX: 334.48 (-0.15), JNJ: 104.43 (-2.29), COH: 35.20 (+0.74), AA: 14.87 (-0.29), LB: 83.39 (+0.24), AZO: 604.73 (+2.34), GILD: 104.13 (-0.18), ALXN: 186.90 (-4.72), MCD: 90.62 (-0.35), DG: 69.80 (+0.65), VZ: 45.58 (-0.78), HRB: 31.96 (+0.20)

Coca-Cola Enterprises Rises 2.34% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Dec 02, 4:39PM CST
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $43.44 to a high of $44.56. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $44.12 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CCE: 43.17 (-1.11)

Watch for Coca-Cola Enterprises to Potentially Pullback After Gaining 2.34% Yesterday
Comtex SmarTrend(R) - Tue Dec 02, 4:38PM CST
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $43.44 to a high of $44.56. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $44.12 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CCE: 43.17 (-1.11)

FEMSA Buys Drugstore Chain, Expands in Small-box Segment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 3:20PM CST
In an effort to further diversify its product portfolio and expand in the small-box retail segment, Fomento Economico Mexicano SAB de CV (FMX) or FEMSA, has agreed to fully acquire Mexican drugstore operator, Farmacias Farmac??n.
KO: 40.91 (-0.62), KOF: 85.05 (-1.24), FMX: 83.02 (-0.79), CCE: 43.17 (-1.11)

Fitch Affirms CCE'S IDR at 'BBB+/F2'; Outlook Stable
Business Wire - Mon Dec 01, 4:59PM CST
Fitch Ratings has affirmed Coca-Cola Enterprises, Inc.'s (CCE's) ratings as follows:
CCE: 43.17 (-1.11)

Tracking Dan Loeb's Third Point Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 24, 1:26AM CST

FNSR: 18.40 (-0.04), ROP: 149.89 (-3.14), ENR: 125.55 (-2.06), CTXS: 60.00 (-2.31), ENPH: 12.45 (-0.10), AAL: 49.97 (-0.56), IACI: 62.23 (-0.64), WMB: 42.76 (-1.37), DG: 69.80 (+0.65), ABBV: 65.27 (-1.76), TMUS: 25.31 (-0.33), MC: 33.02 (-0.93), FDX: 175.79 (-1.09), RAX: 45.39 (-0.86), LNG: 64.88 (+0.93), TAP: 72.37 (-2.42), STZ: 90.78 (-1.68), YPF: 24.04 (-2.77), FDO: 79.25 (-0.23), AZN: 71.80 (-1.80), AIG: 54.05 (-1.13), DOW: 43.35 (-2.66), BID: 38.82 (+0.06), ASH: 115.61 (-1.13), ACT: 259.00 (-4.00), LBTYK: 46.38 (-0.73), CCK: 48.54 (-0.75), ALLY: 22.19 (-0.45), XON: 27.01 (+0.35), CCE: 43.17 (-1.11), BIOF: 7.28 (+0.01), AGN: 208.47 (-2.67), T: 32.16 (-0.55), ST: 51.16 (-0.86), EBAY: 55.77 (-1.01), LBTYA: 48.25 (-0.50), S: 4.08 (-0.32), SHPG: 213.70 (-0.41), WAG: 74.50 (+1.49), APC: 73.34 (-1.91), HRB: 31.96 (+0.20), BUD: 110.33 (-2.36), HTZ: 21.33 (-1.01), AMGN: 164.53 (-1.55), FMC: 55.00 (-0.82), MAS: 24.05 (-0.47), DISH: 70.83 (+0.22), EQT: 79.04 (+0.71), BBBY: 72.25 (+0.47), PH: 123.08 (-3.00), CF: 248.80 (-3.12), SUNE: 18.55 (-0.47), FLT: 138.33 (-4.65), VZ: 45.58 (-0.78), AVGO: 99.20 (-1.35), BABA: 105.11 (+0.14)

Will Coca-Cola Enterprises (CCE) Return to Growth in 2015? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 5:30PM CST
On Nov 19, we issued an updated research report on Coca-Cola Enterprises Inc. (CCE).
DPS: 70.21 (-0.82), KO: 40.91 (-0.62), MNST: 105.11 (-3.28), CCE: 43.17 (-1.11)

Coca-Cola Enterprises Set to Possibly Pullback After Yesterday's Rally of 2.27%
Comtex SmarTrend(R) - Mon Nov 17, 5:49PM CST
Coca-Cola Enterprises (NYSE:CCE) traded in a range yesterday that spanned from a low of $42.28 to a high of $43.31. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $43.11 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CCE: 43.17 (-1.11)

Coca-Cola Enterprises Offers Value But Has Low Earnings Growth
Abba's Aces - at Seeking Alpha - Sat Nov 15, 5:07PM CST

CCE: 43.17 (-1.11)

David Winters Ravages Coca-Cola's Board Once Again, Stating The Dividend Is At Risk
Alexander J. Poulos - at Seeking Alpha - Fri Nov 14, 6:44PM CST

KO: 40.91 (-0.62), MNST: 105.11 (-3.28), GIS: 52.10 (-0.38), CCE: 43.17 (-1.11)

Coca-Cola Enterprises, Inc. to Webcast 2015 Outlook Conference Call
Business Wire - Thu Nov 13, 3:10PM CST
Coca-Cola Enterprises (NYSE: CCE) (Euronext Paris: CCE) will host a conference call with analysts and investors on Thursday, December 18 at 10:00 a.m. EST, 3:00 p.m. GMT, and 4:00 p.m. CET. John F. Brock, chairman and chief executive officer, and Nik Jhangiani, senior vice president and chief financial officer, will provide an update on 2014 business trends and discuss the company's outlook for 2015.
CCE: 43.17 (-1.11)

Technical Analysis on Soft Drinks Equities - PepsiCo, Cott, Monster Beverage, Coca-Cola Enterprises, and Dr. Pepper Snapple
PR Newswire - Thu Nov 13, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: PepsiCo Inc. (NYSE: PEP), Cott Corporation (NYSE: COT), Monster Beverage Corporation (NASDAQ: MNST), Coca-Cola Enterprises Inc. (NYSE: CCE), and Dr Pepper Snapple Group Inc. (NYSE: DPS). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, November 12, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,612.20, down 0.02% and the NASDAQ Composite closed at 4,675.14, up 0.31%. The S&P 500 finished the session 0.07% lower at 2,038.25. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Consumer Staples Sector Index ended the day at 492.37, up 0.01%, with the index advancing 8.45% in the previous three months. Register for your complimentary reports on these five stocks at:
DPS: 70.21 (-0.82), MNST: 105.11 (-3.28), COT: 6.45 (-0.09), CCE: 43.17 (-1.11), PEP: 94.74 (-1.55)

Coca-Cola Enterprises Earnings In Retrospect: Up 1.2% in the Last 18 Days (CCE)
Comtex SmarTrend(R) - Mon Nov 10, 8:32AM CST
Two weeks ago on October 23rd, 2014 Coca-Cola Enterprises (NYSE:CCE) reported earnings and analysts, on average, expected earnings of $0.88 on sales of $2.2 billion. The company actually reported EPS of $0.92 on sales of $2.1 billion, beating EPS estimates by $0.04 and missing revenue estimates by $84.3 million. Shares of Coca-Cola Enterprises have climbed from $42.20 to $42.72, representing a gain of 1.2% since the company reported earnings 18 days ago.
CCE: 43.17 (-1.11)

10 Dividend Growth Stocks For November 2014
FerdiS - Seeking Alpha - Tue Nov 04, 2:41PM CST
One of my goals for 2014 is to balance DivGro's holdings across all 10 sectors in my watch list . Rather than targeting an equal number of holdings in each sector, I prefer to target a distribution proportional to the number of candidates in each...
CMS: 33.55 (-0.14), NVO: 44.48 (-1.14), ALB: 55.60 (-2.27), QCOM: 70.58 (-1.41), HMN: 31.93 (-0.73), CPA: 95.47 (-2.08), HP: 60.34 (-1.33), GPS: 39.90 (+0.01), VZ: 45.58 (-0.78), CCE: 43.17 (-1.11)

3 Takeaways From Coca-Cola Enterprises' Earnings
William Bias - at Seeking Alpha - Mon Nov 03, 6:11AM CST

KO: 40.91 (-0.62), CCE: 43.17 (-1.11)

International Paper Or Coca-Cola Enterprises - Which Makes Sense For A Dividend Growth Portfolio?
The DGI Plan - at Seeking Alpha - Fri Oct 31, 1:46PM CDT

IP: 53.15 (-1.27), CCE: 43.17 (-1.11)

Is Coca-Cola Enterprises Inc Spending This $1 Billion Wisely?
Ted Cooper, The Motley Fool - Motley Fool - Fri Oct 31, 9:00AM CDT
Last December, Coca-Cola Enterprises announced it would repurchase an additional $1 billion of its shares in the coming years -- its fourth such authorization in as many years. At the time, Coca-Cola Enterprises' stock was at an all-time high,...
CCE: 43.17 (-1.11)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 3

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 6

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 5

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
Chicago Scenic Studios’ Equipment Up for Grabs in Auction

Updated Category News Views 8

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

Continue Reading
Ama La Vida's New Coaching: More Than a Financial Plan

Updated Category News Views 1

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 4

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 5

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 6

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 8

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 6

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading

Top 5 Most Recently Viewed Articles

Highland Opportunities and Income Fund Unveils Monthly Payout Plans

Updated Category News Views 288

Highland Opportunities and Income Fund Announces Monthly Distribution The Highland Opportunities and Income Fund (NYSE: HFRO) has made an exciting announcement for its investors. The Fund is set to distribute $0.0385 per share for its common stock. This regular monthly distribution showcases the commitment of HFRO to return value to its shareholders. Understanding the...

Continue Reading
Invivyd Showcases PEMGARDA™ Advances at IDWeek 2024

Updated Category News Views 330

Invivyd Outlines Significant Findings on PEMGARDA™ at IDWeek 2024 Invivyd, Inc. (Nasdaq: IVVD), a dedicated biopharmaceutical enterprise, is set to present groundbreaking findings related to its investigational monoclonal antibody, pemivibart, at the much-anticipated IDWeek 2024 conference. Here, researchers and healthcare professionals will gather in Los Angeles to...

Continue Reading
AI's Impact on Software Engineering: Skills and Challenges Ahead

Updated Category News Views 249

AI's Remarkable Transformation of Software Engineering The world of software engineering is undergoing a significant transformation thanks to artificial intelligence (AI), redefining the roles engineers play and the skills necessary for success. A recent survey highlights that as AI continues to integrate into engineering practices, the fundamental aspects of this...

Continue Reading
Record Participation at the 5th Future Minerals Forum Examined

Updated Category News Views 108

5th Future Minerals Forum Successfully Concludes The recent edition of the Future Minerals Forum achieved impressive milestones with a remarkable attendance of 21,500 participants. This event marked a significant convergence of industry leaders, including investment executives, mining company heads, and experts from various technical fields around the globe. Key Agreement...

Continue Reading
Floreo's New Scientific Advisory Board Champions VR Therapy

Updated Category News Views 254

Floreo's New Scientific Advisory Board Champions VR Therapy Floreo, a trailblazer in virtual reality (VR) therapy for neurodivergent individuals, proudly announces the formation of its inaugural scientific advisory board. The board will consist of six distinguished leaders from the realms of behavioral health research, clinical practice, and healthcare delivery, enhancing...

Continue Reading